FDA approves Priovant’s Lisraya for dermatomyositis
FDA approves Priovant’s Lisraya for dermatomyositis PMLiVE
Regulatory Approvals
FDA approves AstraZeneca’s oral SERD for breast cancer despite negative adcomm vote
FDA approves AstraZeneca’s oral SERD for breast cancer despite negative adcomm vote Endpoints News
FDA approves new drug for pancreatic cancer. Who’s eligible and how does it work?
FDA approves new drug for pancreatic cancer. Who’s eligible and how does it work? WTNH.com
FDA Approves Iberdomide: A New Oral Paradigm in Multiple Myeloma Care
FDA Approves Iberdomide: A New Oral Paradigm in Multiple Myeloma Care Oncology Nursing News
Unpacking Iberdomide’s FDA Approval and The Future of CELMoDs
Unpacking Iberdomide’s FDA Approval and The Future of CELMoDs CancerNetwork